Posts Tagged 'cholesterol study'

FDA: Trilipix May Not Cut Heart Attack Risk

The FDA changed the label for the cholesterol-lowering medicine Trilipix (fenofibric acid) and is notifying healthcare professionals that the drug “may not lower a patient’s risk of having a heart attack or stroke.”

Click here to read more…

 


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 437 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101

Email: info@hkllp.com

Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.